Blue Horseshoe Stocks: PVSP, MJMD Recaps & More

Pervasip Corp. PVSP

Our first order of business in yesterday’s premarket report was to call attention back to PVSP, and the timing turned out to be excellent.

The stock touched a daily low of .0018 just after 10AM, and spent most of the rest of the session bulling its way to new highs. Shortly after 2PM, it hit .0028. That registers as a 55% intraday gain.

PVSP was trading at an absolute bottom (.0001) as recently as February 28th, meaning that yesterday’s high represented a ridiculously strong upswing of 2700% in under a month!

We’ll continue to keep PVSP in mind as we await further updates on last week’s acquisition of a Colorado-based hydroponics distributor. >> READ PR


MediJane Holdings, Inc. MJMD

MJMD appeared in our extended watchlist yesterday, and turned out to be another impeccably-timed alert. The momentum we observed in the stock during a routine scan on Friday made its inclusion on our radar a no-brainer.

MJMD exploded out of the gate at .005 and ran hard, reaching its peak at .02, and marking an exceptional intraday run of 300% It did so on nearly ten times its 30-day average volume, so big cheers go out to any of our readers who were able to hitch a ride on that freight train!

It’s good to see some liquidity flowing back into cannabis stocks, which endured a noticeable slump in recent months. Another one that caught our eye with a big move yesterday was LGBI, and we’ll be on the lookout for any dip-and-rip chances it may provide.


Kraft Foods Group, Inc. KRFT – Options

As our regular reader are surely aware, we’ve been tracking KRFT Calls ever since the big news of the Heinz merger came across the wires last week. Our initial ideas were to monitor April 17th, $75, $80, and $85 Calls and it worked out in spades as the stock approached the $90-mark on Friday.

Yesterday continued the upward momentum, leading KRFT to break $90, and that left a couple of our observed contracts in a good position to continue their gains. While the $70’s were pushed a little deep into the money to make any further appreciable moves, the $75’s and $80’s still managed to provide opportunities for daytrades.

04/17 $80 Calls – Range: 7.90-10.30 – Max Gain: 30%
04/17 $85 Calls – Range:3.40-5.61 – Max Gain: 65%

Those traders savvy enough to roll their strike price up to the $90-level would have been duly rewarded as the 04/17 $90 Calls made their way from .91-1.91, for a 110% intraday move. Should KRFT continue its upward momentum, those will most likely be an area of interest for us in coming sessions.


Extended Watchlist:
AXPW, DANG, HKTV, BGMD, BCRX, CANF, CHTR, PCLN

Blue Horseshoe Stocks: RSH Update & More

Radio Shack Corp. RSH

RSH has made regular appearances in our reports over the past couple of months, starting in the beginning of August, when we caught the stock off of its 52-week low of .55.

Following a major run-up to the 1.60-range on August 29th, the stock has been under a general consolidation amid bankruptcy rumors. This week, the company was hinting at possible refinancing deal that would allow them to avoid that situation for the time being, and this morning, that deal was confirmed.

As a result, the stock is up significantly today, having traded as high 1.65 in the premarket. We’re going to want to see support hold at previous resistance points at 1.15 and 1.30. Already, at today’s early highs, we’re seeing more than a 100% increase off of the lows we observed following our most recent RSH alert (.80)


Rockwell Medical, Inc. RMTI

RMTI is another morning gapper that we’re going to place on watch today. With the stock coming off of a recent bottom, it’s going to be interesting to see how today’s development affects its price action.

The company put out a hefty PR this morning regarding a commercialization/distribution deal with Baxter Healthcare (BAX):

WIXOM, Mich., Oct. 3, 2014 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (BAX), to commercialize Rockwell’s hemodialysis concentrate product line in the U.S. and in select overseas markets.>> VIEW PR


BioCryst Pharmaceuticals, Inc. BCRX

BCRX appeared on Wednesday in our extended watchlist, and what has followed has been two fruitful sessions in a row. From a low of 9.89 on Wednesday, we witnessed as the stock bulled its way into yesterday’s close, reaching a daily high of 11.49, a solid 16% overnight increase.


Inovio Pharmaceuticals, Inc. INO

Speaking of pharma plays, INO, a stock that has appeared several times in our reports recently, is also making moves concurrently with the present concern over the Ebola virus outbreak. The company actually has a Ebola vaccine with which they’ve reported success in treating animals with the deadly virus. Anything to do with Ebola is getting a lot of attention at present, and INO is no exception.


Side Note:

Jobs numbers were out this morning, to a positive reception. We will subsequently be looking for dip-and-rip opportunities with regard to options trading. Friday is characteristically a day when premiums start to come down as a result of time decay, with expirations looming. We’re looking at potential opportunities trading Calls in plays like SPY, AA, ISRG, & GPRO.


Extended Watchlist:
HALO, JBLU, WAVX, IAG, SFUN, NXTD

Blue Horseshoe Stocks: Bottom Play Alert, HEB & More

FBC Holdings, Inc. FBCD

We wanted send out an alert on FBCD this morning, if for no other reason than the fact that it’s been quite awhile since we found a bottom play trading near all-time lows in the super-subpenny range. We’ve definitely been known to do some bottom-fishing in our day, with some of our biggest wins coming from bargain shopping.

What we have in FBCD is a stock that has been beaten back to a record low of .0005 (reached yesterday) which catches our attention in a big way. We are going to stay vigilant as we monitor this play for a solid bottom, because a snapback to to the double-zero range is not only very possible, but also has the potential to happen quite rapidly.

With so little room to the downside, one might classify FBCD as a “lottery ticket” type of play. The action on super-subpennies have the potential to return exponential gains, which is why we’re going to give it a spot on our running watchlist.

A quick glance at the chart shows that each time an influx of volume has come into the stock, it makes a run to test its 50DMA. From present levels, a jump to the current 50DMA would mean a chance for gains of at least 66%


Hemishperx BioPharma, Inc. HEB

We were passively tracking HEB via our extended watchlist last month, and are going to keep giving it our attention as the new quarter kicks off today. The stock is gapping up to the tune of roughly 25% in the premarket.

We caught notice of HEB following the company’s announcement that it would collaborate with US Army Medical Research to develop treatments to attempt to overcome the emergence of drug resistance due to Ebola virus mutation.

With the current Ebola breakout making it a hot-button topic, and the company stating this week that it would be expanding its Ebola research, we’re going to still be keeping our ears to the ground on this one.


Spherix, Inc. SPEX

SPEX made an appearance in yesterday morning’s extended watchlist and had one heck of a solid session. The stock came out of the gate and ran from a low of .99 all the way up to 1.58, offering us the chance to bank up to 60% in profits as it traded more than 13.5X its 3-month average volume.

Disappointment over the delay of some upcoming litigation that Shperix has against VTech and Uniden (View PR) is the apparent cause of the stock’s gapping down in today’s premarket.


Extended Watchlist:
LAKE, BCRX, ANGI, RVP, NNVC, CGA

Blue Horseshoe Stocks: Update on AAPL & Extended Watchlist

Apple, Inc. AAPL – Options

On Friday, our morning report contained a blurb in which we stated we’d be “hot on the trail of potential gains in the Apple options chain”, and we certainly hope folks got in on some of the action that ensued. We have been following AAPL quite heavily since our report on Wed. the 14th, wherein we commented on the Apple-Beats buyout rumor.

AAPL stock tore out of the gate, bulling its way up all day to more than $614 just prior to the close. As a result, the options contracts we were following in the $605-610 range steadily ramped up in price over the course of the session.

As you can see on the graphic below, some truly notable gains were possible for anyone trading these contracts. The daily ranges on these things were quite impressive:

$605 Calls – Day’s Range: 2.15-9.76 – Max Gain: 354%

$607 Calls – Day’s Range: .83-7.13 – Max Gain: 759%

$610 Calls – Day’s Range: .25-4.70 – Max Gain: 1780%

It really wouldn’t have mattered which Calls you were into on Friday- traders literally could have thrown a dart at a board filled with contracts and come up with a winner!

AAPL continued to press upward this morning, as the stock has traded as high as the 618.90’s in pre-market activities. Now that it has broken well above the previous resistance point of $607.33, that’s the level we’d like to see hold as support in the event of any pullbacks.

Other stocks that had significant gains in the options calls from last week that we want to continue to monitor this week include: DDD, TSLA, GOGO, DDD & FEYE



Side Note:

Triton Distribution Systems, Inc. TTDZ now trading as:
Green Cures & Botanical Distribution Inc. GRCU

TTDZ, a stock that has given us many chances to profit in 2014, finally underwent the name and symbol change that we had been anticipating, becoming GRCU.

If you recall, this play was one of the largest runners we encountered during the “green rush” earlier this year. We caught it at a low of .0012 on January 30th, and subsequently rode it to a high of .049 in early April. For anyone without a calculator handy, that equates to a staggering move of 3983% in just over two months time! It’s hard not to call that one of our biggest successes of the year so far.

The company has also gone live with a new website that you can find @ http://gcbdinc.com/

We’re going to begin monitoring this, and other marijuana related plays more heavily in coming weeks. As many of you will remember, we’re anxiously awaiting the start of legal sales in Washington State, presently slated for mid-July. It could very well provide the cannabis sector with another swell of interest and buying, much like the beginning of sales in Colorado did back in January, which of course sparked one of the most monumental sector surges the penny markets have ever seen.


Extended Watchlist:
BCRX, ARO, VRNG, INO, SPEX, ADXS

TTDZ, DEWM & Extended Watchlist

Triton Distribution Systems, Inc. TTDZ

Yesterday’s alert on TTDZ offered up opportunity for all, as the stock exploded out of the gate, trading from a low of .0052 all the way up to .009. That marked an intraday spike of 73% on nearly three times the 3-month average volume. Yesterday’s high represents a gain of 650% from our initial alert-low of .0012 on January 30th.

Perhaps most significantly is the fact that the stock finished out the session at .0088, very close to its high of day, and appears to want to gap up this morning.

As always, we need to watch carefully for the point where the stock runs out of steam, at which time we’ll be waiting for a pullback to lead to a future bounceplay opportunity. It’s all about being sharp-eyed and playing the current trend.


Dewmar International BMC, Inc. DEWM

DEWM, which has already afforded us gains in the 700%-range had some marijuana-related news out this morning that’ll lead us to watch this stock like a hawk today. The trading community has welcomed Dewmar’s intent to enter into the cannabis sector as evidenced by the hefty spikes on the chart we’ve witnessed. Today’s news furthers the company’s goals to that end, as they’ve announced the acquisition of a new subsidiary to house the company’s current and future cannabis holdings.

This is a story that we will definitely be paying attention to, as they attempt to become a player in the hemp industry, fueled by the Fed’s recently legalizing the cultivation of industrial hemp.

HOUSTON, TX–(Marketwired – Feb 20, 2014) – Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) (“Dewmar” or “Company”), a leading provider of consumer brands to global markets announced that it has secured U.S. Hemp Corporation, Inc. d/b/a United States Hemp Corporation as a wholly-owned subsidiary for the purpose of holding and marketing the future hemp-related assets of Dewmar. >>> FULL PR


Extended Watchlist:
DIRV, MEET, ATRS, BCRX, BBRY (Options: Feb. 28th $10 Calls)

Get Our FREE Daily Reports!